Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1970 1
1972 2
1973 1
1974 1
1975 2
1976 1
1977 2
1978 1
1979 1
1981 2
1982 2
1983 4
1984 5
1986 1
1987 4
1988 2
1989 7
1990 11
1991 15
1992 6
1993 10
1994 15
1995 10
1996 6
1997 9
1998 13
1999 10
2000 6
2001 17
2002 16
2003 12
2004 15
2005 12
2006 17
2007 23
2008 37
2009 36
2010 40
2011 52
2012 40
2013 51
2014 42
2015 43
2016 41
2017 53
2018 57
2019 60
2020 80
2021 105
2022 76
2023 85
2024 96
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,121 results

Results by year

Filters applied: . Clear all
Page 1
Urinary Single-Cell Profiling Captures the Cellular Diversity of the Kidney.
Abedini A, Zhu YO, Chatterjee S, Halasz G, Devalaraja-Narashimha K, Shrestha R, S Balzer M, Park J, Zhou T, Ma Z, Sullivan KM, Hu H, Sheng X, Liu H, Wei Y, Boustany-Kari CM, Patel U, Almaani S, Palmer M, Townsend R, Blady S, Hogan J, Morton L, Susztak K; TRIDENT Study Investigators. Abedini A, et al. Among authors: patel u. J Am Soc Nephrol. 2021 Mar;32(3):614-627. doi: 10.1681/ASN.2020050757. Epub 2021 Feb 2. J Am Soc Nephrol. 2021. PMID: 33531352 Free PMC article.
A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection.
Mayer KA, Schrezenmeier E, Diebold M, Halloran PF, Schatzl M, Schranz S, Haindl S, Kasbohm S, Kainz A, Eskandary F, Doberer K, Patel UD, Dudani JS, Regele H, Kozakowski N, Kläger J, Boxhammer R, Amann K, Puchhammer-Stöckl E, Vietzen H, Beck J, Schütz E, Akifova A, Firbas C, Gilbert HN, Osmanodja B, Halleck F, Jilma B, Budde K, Böhmig GA. Mayer KA, et al. Among authors: patel ud. N Engl J Med. 2024 Jul 11;391(2):122-132. doi: 10.1056/NEJMoa2400763. Epub 2024 May 25. N Engl J Med. 2024. PMID: 38804514 Clinical Trial.
Diabetic kidney disease: a report from an ADA Consensus Conference.
Tuttle KR, Bakris GL, Bilous RW, Chiang JL, de Boer IH, Goldstein-Fuchs J, Hirsch IB, Kalantar-Zadeh K, Narva AS, Navaneethan SD, Neumiller JJ, Patel UD, Ratner RE, Whaley-Connell AT, Molitch ME. Tuttle KR, et al. Among authors: patel ud. Diabetes Care. 2014 Oct;37(10):2864-83. doi: 10.2337/dc14-1296. Diabetes Care. 2014. PMID: 25249672 Free PMC article.
PROTAC-mediated NR4A1 degradation as a novel strategy for cancer immunotherapy.
Wang L, Xiao Y, Luo Y, Master RP, Mo J, Kim MC, Liu Y, Maharjan CK, Patel UM, De U, Carelock ME, Tithi TI, Li X, Shaffer DR, Guertin KR, Zhuang H, Moser E, Smalley KSM, Lv D, Zhou D, Zheng G, Zhang W. Wang L, et al. Among authors: patel um. J Exp Med. 2024 Mar 4;221(3):e20231519. doi: 10.1084/jem.20231519. Epub 2024 Feb 9. J Exp Med. 2024. PMID: 38334978 Free PMC article.
A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer.
Patil VM, Noronha V, Joshi A, Agarwal J, Ghosh-Laskar S, Budrukkar A, Murthy V, Gupta T, Mahimkar M, Juvekar S, Arya S, Mahajan A, Agarwal A, Purandare N, Rangarajan V, Balaji A, Chaudhari SV, Banavali S, Kannan S, Bhattacharjee A, D'Cruz AK, Chaturvedi P, Pai PS, Chaukar D, Pantvaidya G, Nair D, Nair S, Deshmukh A, Thiagarajan S, Mathrudev V, Manjrekar A, Dhumal S, Maske K, Bhelekar AS, Nawale K, Chandrasekharan A, Pande N, Goel A, Talreja V, Simha V, Srinivas S, Swami R, Vallathol DH, Dsouza H, Shrirangwar S, Turkar S, Abraham G, Thanky AH, Patel U, Pandey MK, Prabhash K. Patil VM, et al. Among authors: patel u. Cancer. 2019 Sep 15;125(18):3184-3197. doi: 10.1002/cncr.32179. Epub 2019 May 31. Cancer. 2019. PMID: 31150120 Free article. Clinical Trial.
Erythrodermic lichen planus.
Rose AE, Patel U, Chu J, Patel R, Meehan S, Latkowski JA. Rose AE, et al. Among authors: patel u. Dermatol Online J. 2011 Oct 15;17(10):26. Dermatol Online J. 2011. PMID: 22031652 Review.
Autoimmune Disorders and the Eye.
Thompson L, Patrianakos T, Garcia J, Wadhwa A, Yang E, Thomas C, Schneider R, Stern H, Palma C, Hill K, Barquet V, Anderson-Nelson S, McMahon K, Patel U, Ghadiali Q, Danek D, Larsen B, Wong A, Dawood S, Ludington M, Zhang G, Garakani R, Dwarakanathan S, Simotas A, Sangal K, Phelps P, Ashourian T, Darwish D, Bamba S, Zein M, Nichols J, To J, Sarmiento A, Chaudhary S, Breshears B, Nelson J, Anderson-Nelson S, Giovingo M. Thompson L, et al. Among authors: patel u. Dis Mon. 2024 May;70(5):101711. doi: 10.1016/j.disamonth.2024.101711. Epub 2024 Apr 12. Dis Mon. 2024. PMID: 38609837 Review. No abstract available.
Opioid Use Disorder: Treatments and Barriers.
Patel K, Bunachita S, Agarwal AA, Lyon A, Patel UK. Patel K, et al. Among authors: patel uk. Cureus. 2021 Feb 6;13(2):e13173. doi: 10.7759/cureus.13173. Cureus. 2021. PMID: 33717718 Free PMC article. Review.
Felzartamab in Antibody-Mediated Rejection. Reply.
Böhmig GA, Patel UD, Halloran PF. Böhmig GA, et al. Among authors: patel ud. N Engl J Med. 2024 Sep 26;391(12):1162-1163. doi: 10.1056/NEJMc2409970. N Engl J Med. 2024. PMID: 39321372 No abstract available.
1,121 results